Search

Search Results

• 

  Short story of antirheumatic therapy.VIII. The immunodepressants

  G. Pasero, P. Marson

  44-54

  19-03-2012

  https://doi.org/10.4081/reumatismo.2012.44

  1729

  PDF: 1534
• 

  Cytomegalovirus ileocolitis in a rheumatoid arthritis patient: case report and literature review

  M. S. Dag, I. H. Turkbeyler, Z. A. Ozturk, B. Kısacık, E. Tutar, A. Kadayıfçı

  13-16

  30-06-2015

  https://doi.org/10.4081/reumatismo.2015.793

  2714

  PDF: 1118
• 

  Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

  R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni

  83-89

  09-09-2016

  https://doi.org/10.4081/reumatismo.2016.875

  2058

  PDF: 998

  IL RUOLO DEI LINFOCITI TH9 NELL'ARTRITE REUMATOIDE E NELLA RISPOSTA AL TRATTAMENTO CON INFLIXIMAB.: 607
• 

  Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis

  A. Lo Gullo, G. Mandraffino, C.O. Aragona, A. Molica Colella, A. Saitta, E. Imbalzano

  184-188

  21-12-2017

  https://doi.org/10.4081/reumatismo.2017.1013

  1720

  PDF: 946
• 

  Intracardiac thrombus in Behçet’s disease

  I. Ben Ghorbel, N. Belfeki, M.H. Houman

  148-153

  16-12-2016

  https://doi.org/10.4081/reumatismo.2016.887

  3275

  PDF: 1541

• PO:35:223 | Biologic therapy for sustained remission in eosinophilic myocarditis: real-world evidence from a tertiary center experience Federica Davanzo¹, Caterina Menghi², Andrea Silvio Giordani², Anna Baritussio², Federico Scognamiglio², Cristina Vicenzetto², Luca Iorio¹, Renzo Marcolongo², Cristina Basso³, Andrea Doria¹, Roberto Padoan¹, Alida Linda Patr Caforio² | ¹Rheumatology Unit, Department of Medicine, University of Padua Padova, Italy; ²Cardiology Unit, Department of Cardiac, Vascular, Thoracic Sciences and Public Health, University of Padua Padova, Italy; ³Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2383

  20

• PO:31:169 | From Crisis to Chronicity: A Real-World Study of Renal Dysfunction in Systemic Sclerosis Stefano Stano¹, Fabio Cacciapaglia^1|2, Giorgia Campanale¹, Simone Perniola¹, Maria Morrone¹, Andrea Cito¹, Vincenzo Venerito¹, Maria Grazia Anelli¹, Giuseppe Lopalco¹, Florenzo Iannone¹ | ¹Rheumatology Unit - Department of Precision and Regenerative Medicine, Jonian Area DiPReMeJ, University of Bari Bari, Italy; ²Rheumatology Service, Internal Medicine Unit F. Miulli General Hospital, Department of Medicine and Surgery, LUM Casamassima, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2368

  18
• 

  Systemic lupus erythematosus and infections

  B.K. Singh, S. Singh

  154-169

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1303

  5095

  PDF: 2948

• PO:11:162 | DRESS syndrome: a case treated with mepolizumab Alessandro Belotti Masserini¹, Stefania Bertocchi¹, Eleonora Bruschi¹, Silvia Breda¹, Valeria Rossi¹, Elide Lupi¹, Tania Ubiali¹, Fabrizio Angeli¹, Massimiliano Limonta¹ | ¹ASST Papa Giovanni XXIII, Bergamo, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2152

  153

• Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

  S. Zingarelli, P. Airò, M. Frassi, C. Bazzani, M. Scarsi, M. Puoti

  22-27

  https://doi.org/10.4081/reumatismo.2008.22

  1276

  PDF: 1073

• PO:18:264 | Anifrolumab in Systemic Lupus Erythematosus: Bridging Clinical Trial Data with Real-World Evidence Giulia Cassone², Filippo Santoro¹, Caterina Vacchi², Dilia Giuggioli², Chiara Cabassi¹ | ¹UOC Reumatologia, AOU Policlinico di Modena, Università degli studi di Modena e Reggio Emilia Modena e Reggio Emilia, Italy; ²UOC Reumatologia, AOU Policlinico di Modena Modena, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2337

  57

• PO:35:234 | Sustained Vasculitis Quiescence and CS Reduction with Mepolizumab 100 mg Francesca Mascia¹, Angelo Fassio², Marco Zurlo¹, Davide Chesini³, Francesco Pollastri², Giovanni Adami², Davide Gatti⁴, Maurizio Rossini⁴, Matteo Maule⁵, Gianentrico Senna¹, Marco Caminati¹ | ¹University of Verona - Allergology and Clinical Immunology Verona, Italy; ²Policlinico G. B. Rossi - Rheumatology Verona, Italy; ³University of Verona - Faculty of Medicine and Surgery Verona, Italy; ⁴University of Verona - Rheumatology Verona, Italy; ⁵Policlinico G. B. Rossi - Allergology and Clinical Immunology Verona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2387

  14
• 

  Adult-onset systemic autoinflammatory disorders: a clinical approach

  T. Borges, A. Barbosa, S. Silva

  177-188

  28-01-2020

  https://doi.org/10.4081/reumatismo.2019.1192

  4536

  PDF: 2634

• Wars in the history of rheumatology

  G. Pasero, P. Marson

  332-337

  https://doi.org/10.4081/reumatismo.2007.332

  1559

  PDF: 1031
• 

  Infliximab in the treatment of Budd-Chiari syndrome in Behçet’s disease

  L.B. Santos, J. Rigueira, A.P. Vilas

  163-165

  24-10-2019

  https://doi.org/10.4081/reumatismo.2019.1153

  1569

  PDF: 909

• TNFα blockers and infectious risk in rheumatoid arthritis

  B. Raffeiner, C. Botsios, F. Ometto, L. Bernardi, A. Montante, P. Sfriso, S. Todesco, L. Punzi

  165-173

  https://doi.org/10.4081/reumatismo.2009.165

  1954

  PDF: 2178